Talk:Tumor antigen
From Wikipedia, the free encyclopedia
 |
This article is within the scope of WikiProject Medicine. Please visit the project page for details or ask questions at the doctor's mess. |
| Start | This page has been rated as Start-Class on the quality assessment scale |
| Low | This article has been rated as Low-importance on the importance assessment scale |
 |
This article is within the scope of the Molecular and Cellular Biology WikiProject. To participate, visit the WikiProject for more information. The WikiProject's current monthly collaboration is focused on improving Restriction enzyme. |
||
| Start | This article has been rated as start-Class on the assessment scale. |
||
| Low | This article is on a subject of low-importance within molecular and cellular biology. | ||
|
Article Grading: The article has been rated for quality and/or importance but has no comments yet. If appropriate, please review the article and then leave comments here to identify the strengths and weaknesses of the article and what work it will need. |
|||
 To-do list for Tumor antigen: |
edit · history · watch · refresh | ||
|---|---|---|---|
|
|||
[edit] Tumor antigen vs. tumor marker
Please note that tumor antigen is different from tumor marker. Some tumor antigens can be used as tumor markers but the primary feature of tumor antigens is their immunogenecity whereas the primary feature of tumor markers is easy estimation / detectability so that they can be used for screening or as prognostic indicators. So please do not merge the two articles. - TwoOars (Rev) 20:43, 28 September 2007 (UTC)
[edit] Direct injection of adjuvants?
As a general question, why is there so much focus on developing specific tumor antigens, rather than developing adjuvants that might be directed into tumors in situ? We know the antigens are present in tumors already, often vary between patients, and tend to be expensive, whereas adjuvants could potentially be a very cheap treatment. I would think that if a battery of noxious substances like Freund's Complete Adjuvant or urushiols were tested by direct injection into tumors there would be at least some possibility that one of them might stimulate an immune response against extracellular antigens, but it doesn't seem like the idea is being pursued. Mike Serfas 13:56, 29 September 2007 (UTC)
[edit] WikiProject class rating
This article was automatically assessed because at least one WikiProject had rated the article as start, and the rating on other projects was brought up to start class. BetacommandBot 16:32, 10 November 2007 (UTC)
